$94.68 -1.12 (-1.17%) Vertex Pharmaceuticals Inc - NASDAQ

Aug. 31, 2016 | 09:35 AM
Last Trade: 94.68
Trade Time: Aug 31 09:35 AM Eastern Daylight Time
Change: -1.12 (-1.17%)
Prev Close: 95.80
Open: 95.98
Bid: 94.59
Ask: 95.10
  1. Downside Ahead For Biotech Stocks?

    Benzinga | Jun. 10, 2016 | 15:58PM EST
  1. Vertex Filing For Expanded Kalydeco Label Rejected By FDA

    IBD | Feb. 5, 2016 | 12:48PM EST
  2. Celgene, Vertex, Illumina Offer Mixed Outlooks

    IBD | Jan. 11, 2016 | 19:05PM EST
  3. Vertex Receives Two EU Approvals for KALYDECO for Cystic Fibrosis

    Benzinga | Nov. 18, 2015 | 04:19AM EST
  4. Valeant Dumps Philidor, Falls

    IBD | Oct. 30, 2015 | 18:13PM EST
  5. Alexion, Vertex Steal Mo Stanley's Eyes From Gilead

    IBD | Oct. 2, 2015 | 12:42PM EST
  6. Gilead, Valeant Downgraded; IBM, Dunkin' PTs Cut

    IBD | Oct. 2, 2015 | 08:48AM EST
  7. Wall Street Wobbles as Stocks Try to Rebound

    FoxBusiness | Sep. 29, 2015 | 08:00AM EST
  8. EU panel says yes to key drugs

    IBD | Sep. 25, 2015 | 18:47PM EST
  9. 5 Key Drugs That Just Won EU Endorsements

    IBD | Sep. 25, 2015 | 15:19PM EST
  10. VERTEX PHARMA

    IBD | Jul. 29, 2015 | 18:29PM EST
  11. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  12. Stocks Roll Higher, Trade Mixed

    IBD | Jul. 15, 2015 | 10:58AM EST
  13. CNBC's Meg Tirrel Speculates About Gilead's New Acquisiton

    Benzinga | Jul. 10, 2015 | 06:52AM EST
  14. Regeneron, Amgen Downgraded As Biotech Seen Slowing

    IBD | Jul. 9, 2015 | 11:12AM EST
  15. Vertex's Orkambi Approved For CF, Prices On High Side

    IBD | Jul. 2, 2015 | 16:34PM EST
Trading Center